Status:
NOT_YET_RECRUITING
A Comparative Study of Endoscopic Choanal Canalization and Mitomycin C Application vs Endoscopic Crossover Flap Technique
Lead Sponsor:
Assiut University
Conditions:
Choanal Atresia
Eligibility:
All Genders
Up to 72 years
Phase:
NA
Brief Summary
determine the optimal surgical strategy for achieving 1. long-term outcomes 2. minimizing complications 3. improving outcomes in CCA patients
Detailed Description
Congenital choanal atresia (CCA) is a relatively common congenital nasal anomaly, characterized by the failure of canalization of the posterior nasal passage during embryological development, which no...
Eligibility Criteria
Inclusion
- Age 0-72 months at enrollment.
- Diagnosis of congenital choanal atresia (unilateral or bilateral) confirmed by nasal endoscopy and CT imaging.
- Patients presenting with clinical symptoms (e.g., nasal obstruction, respiratory distress, feeding difficulties) or requiring surgical intervention.
- Guardians willing to provide informed consent and comply with follow-up.
Exclusion
- Acquired (non-congenital) choanal atresia.
- Previous surgical intervention for choanal atresia.
- Significant comorbidities contraindicating surgery (e.g., unstable cardiopulmonary status).
- Incomplete medical records or anticipated inability to complete follow-up.
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2028
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07173023
Start Date
September 1 2025
End Date
September 1 2028
Last Update
September 15 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.